This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...